Renal denervation (RDN)

Find all the latest content on renal denervation (RDN) published on this website.

Despite the existence of effective antihypertensive drugs, arterial hypertension remains a critical challenge for healthcare systems worldwide. Can catheter-based renal denervation (RDN) play an effective part in reducing, previously untreatable high blood pressure? Follow the latest research in this novel field along with the critical issues of blood pressure monitoring, imaging modalities, tools, devices and techniques as well as vascular access, bleeding risk and adjunctive pharmacotherapy…

Filtered By
Renal denervation

93 results

PCRonline @ TCT 2022 - Get the international perspective!

12 Sep 2022

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2022 - check out the list here!

PCRonline @ TCT 2022 - get the international perspective!

Renal denervation for treatment of hypertension – heading for new shore

19 Jul 2022

View this replay of a LIVE Round Table Webinar - Renal denervation for treatment of hypertension - with F. Mahfoud, A. Pathak, K. Tsioufis and T. Zellera

Late-breaking science overview - What did we learn @EuroPCR 2022?

20 May 2022 – From EuroPCR 2022

Watch this video to gain insight into late-breaking studies and trials presented during EuroPCR 2022:

  • Intravascular imaging vs. angiography-guided PCI in high bleeding risk patients
  • Trancatheter Aortic Valve Repair for aortic insufficiency using the Cusper device
  • Angiography-derived coronary microcirculatory assessment in INOCA patients
  • Blood pressure and MACE reductions after renal...
Late-breaking science overview - What did we learn @EuroPCR 2022?

Abbreviated DAPT after complex PCI in high bleeding risk patients

18 May 2022 – From EuroPCR 2022

Luis Ortega Paz interviews Pascal Vranckx on the background, main results and take-home messages from the sub-analysis of the MASTER DAPT study.

Abbreviated DAPT after complex PCI in high bleeding risk patients

Hypertension management in 2022: Latest data on renal denervation

17 May 2022 – From EuroPCR 2022

Ali Nazmi Calik discusses with David Kandzari the current data on the catheter-based renal denervation treatment to reduce blood pressure in patients with hypertension. They discuss more specifically the results from SPYRAL HTN-ON MED 3-year data, the 3-year Global SYMPLICITY Registry and RADIANCE-HTN SOLO and TRIO...

Hypertension management in 2022: Latest data on renal denervation

Interventions for hypertension and heart failure

19 May 2022 – From EuroPCR 2022

View slides and videos on procedures for hypertension and heart failure including observations and outcomes from the RELIEVE-HF roll-in cohort, a novel approach for performing renal denervation, RDN registry of a resistant hypertension multidisciplinary team..

Interventions for hypertension and heart failure

PCR Innovators Day - Competition for the Jon DeHaan Award

19 May 2022 – From EuroPCR 2022

Best-graded contributions for the Innovators Day were considered for this competition. Among them, find out more about transcatheter calcium modifying treatment of the stenotic aortic valve, capture technology for treating mitral regurgitation, or transcatheter microwave renal denervation guided by aorticorenal ganglion pacing.

PCR Innovators Day - Competition for the Jon DeHaan Award

EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!

17 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.

EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!

Advances in renal denervation: from patient selection to procedure

17 May 2022 – From EuroPCR 2022

For this EuroPCR 2022 session, Felix Mahfoud is joined by David Kandzari, Rasha Al-Lamee, Flavio Ribichini, and Andrew Sharp to talk about renal denervation: hear real-life experiences and get the latest preclinical and clinical data on the long-term safety and efficacy of the radiofrequency renal denervation...

Advances in renal denervation: from patient selection to procedure

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation